Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors MH Nelson, CR Dolder Annals of Pharmacotherapy 40 (2), 261-269, 2006 | 243 | 2006 |
Hypnosedative-induced complex behaviours: incidence, mechanisms and management CR Dolder, MH Nelson CNS drugs 22, 1021-1036, 2008 | 184 | 2008 |
Paliperidone for schizophrenia C Dolder, M Nelson, Z Deyo American Journal of Health-System Pharmacy 65 (5), 403-413, 2008 | 94 | 2008 |
Agomelatine treatment of major depressive disorder CR Dolder, M Nelson, M Snider Annals of Pharmacotherapy 42 (12), 1822-1831, 2008 | 90 | 2008 |
Use of non-benzodiazepine hypnotics in the elderly: are all agents the same? C Dolder, M Nelson, J McKinsey CNS drugs 21, 389-405, 2007 | 89 | 2007 |
Deliberate integration of student leadership development in doctor of pharmacy programs KK Janke, MH Nelson, AS Bzowyckyj, DG Fuentes, E Rosenberg, ... American Journal of Pharmaceutical Education 80 (1), 2, 2016 | 64 | 2016 |
Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors MH Nelson, AK Birnbaum, RP Remmel Epilepsy research 44 (1), 71-82, 2001 | 58 | 2001 |
Including emotional intelligence in pharmacy curricula to help achieve CAPE outcomes MH Nelson, KK Fierke, BJ Sucher, KK Janke American journal of pharmaceutical education 79 (4), 48, 2015 | 57 | 2015 |
Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients C Dolder, M Nelson, A Stump Drugs & aging 27, 625-640, 2010 | 53 | 2010 |
The effects of mirtazapine on sleep in patients with major depressive disorder CR Dolder, MH Nelson, CA Iler , 24, 3 24 (3), 215-224, 2012 | 47 | 2012 |
The Regis Model for pharmacy education: A highly integrated curriculum delivered by Team-Based Learning™(TBL) M Nelson, SD Allison, M McCollum, SW Luckey, DR Clark, SM Paulsen, ... Currents in Pharmacy Teaching and Learning 5 (6), 555-563, 2013 | 43 | 2013 |
Variations in parthenolide content and daily dose of feverfew products MH Nelson, SE Cobb, J Shelton American journal of health-system pharmacy 59 (16), 1527-1531, 2002 | 42 | 2002 |
Prevnar 13, the new 13-valent pneumococcal conjugate vaccine AJ Sucher, EB Chahine, M Nelson, BJ Sucher Annals of Pharmacotherapy 45 (12), 1516-1524, 2011 | 41 | 2011 |
Team-based learning in pharmacy: The faculty experience S Tweddell, D Clark, M Nelson Currents in Pharmacy Teaching and Learning 8 (1), 7-17, 2016 | 37 | 2016 |
An elective course in leader development B Sucher, M Nelson, D Brown American Journal of Pharmaceutical Education 77 (10), 224, 2013 | 36 | 2013 |
Assessing emotionally intelligent leadership in pharmacy students RC Haight, C Kolar, MH Nelson, KK Fierke, BJ Sucher, KK Janke American journal of pharmaceutical education 81 (2), 29, 2017 | 30 | 2017 |
Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C LS Smith, M Nelson, S Naik, J Woten Annals of Pharmacotherapy 45 (5), 639-648, 2011 | 29 | 2011 |
A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer MH Nelson, CR Dolder Therapeutics and Clinical Risk Management 3 (4), 665-673, 2007 | 27 | 2007 |
Certolizumab pegol: a TNF-α antagonist for the treatment of moderate-to-severe Crohn's disease LS Smith, M Nelson, CR Dolder Annals of Pharmacotherapy 44 (2), 333-342, 2010 | 23 | 2010 |
A capillary GC-MS method for analysis of phenytoin and [13C3]-phenytoin from plasma obtained from pulse dose pharmacokinetic studies1 MH Nelson, AK Birnbaum, PJ Nyhus, RP Remmel Journal of pharmaceutical and biomedical analysis 17 (8), 1311-1323, 1998 | 18 | 1998 |